钠离子

Sodium ion

HCID 923CAS 17341-25-2

子结构检索查找相似结构

基本信息

标准SMILES: [Na+]
InChIKey: FKNQFGJONOIPTF-UHFFFAOYSA-N
分子式: Na+
平均分子量: 22.9898 g/mol
单同位素质量: 22.98976928

名称与标识

首选名称: Sodium ion
IUPAC: sodium(1+)
中文名: 钠离子
英文名: SODIUM ION
分子式: Na+
分子量: 22.99

名称与别名

sodium ionSodium(1+)sodium cation17341-25-2Sodium, ion (Na1+)Sodium (ion)Sodium ion(1+)LYR4M0NH37124224-04-0Na+4-Aza-5-thiatricyclo[5.2.1.0(3,7)]decane-5,5-dioxide, (7S)-10,10-dimet hyl-Sodium(1+)ions

展开更多名称

钠离子钠表标准液 c(Na+)=100 ppb钠标准溶液 c(Na+)=15 μg/L钠标准溶液 c(Na+)=10 mg/mL钠表标准液 c(Na+)=1000 ppb钠标准溶液 c(Na+)=100 μg/L钠表标液 c(Na+)=0.023 mg/L钠标准溶液 c(Na+)=1000 μg/L钠标准溶液 c(Na+)=230 μg/mL钠标准溶液 c(Na+)=230 μg/mL Codow(氪道)SODIUM ION STANDARDSodium ion (1+)SODIUM STANDARD SOLUTIONSODIUM, ION CHROMATOGRAPHY STANDARD SOLUTIONSodium Ion chromatography standard solution, Na

UNII-LYR4M0NH37sodium(I)Sodium ion(+)Sodium cation(1+)Sodium (Na1+)Sodium ion (Na1+)Sodium (1+)SODIUM ION CHROMATOGRAPHY STANDARD

数据库标识

CAS: 17341-25-2、7440-23-5
PubChem CID: 923
DTXSID: DTXSID8037671
ChEBI: CHEBI:29101
UNII: LYR4M0NH37
Nikkaji: J1.085.483K

性质

结构计算性质

极性表面积: 0 Å²
氢键供体: 0
氢键受体: 0
可旋转键: 0
重原子: 1
形式电荷: 1
复杂度: 0

实验与物化性质

Melting Point97.82 °C

Physical DescriptionSolid

物理化学性质

熔点: 246 °C · 246 °C
密度: 1.013 g/cm3 · 1.013g/cm3 at 20°C
储存条件: 15 · 15-25°C
形态: Liquid
PH值: 7 · 7 (20°C in H2O)
EPA化学物质信息: Sodium ion (17341-25-2)

安全与法规

安全数据

F: 10
wgk: -
包装类别: III
危险等级: 8
存储类别: 10 - Combustible liquids
安全说明: 26-36
危险类别码: 22-36/37/38
危险品运输编号: UN3264

化学与工业

药理信息

FDA Pharmacological Classification · 6 条

LYR4M0NH37

SODIUM CATION

Established Pharmacologic Class [EPC] - Osmotic Laxative

Physiologic Effects [PE] - Increased Large Intestinal Motility

Physiologic Effects [PE] - Inhibition Large Intestine Fluid/Electrolyte Absorption

Mechanisms of Action [MoA] - Osmotic Activity

Tissue LocationsKidney

Cellular LocationsExtracellular；Golgi apparatus；Peroxisome

Metabolite Pathways · 1 条

3-Methylthiofentanyl Action Pathway；Acebutolol Action Pathway；Alfentanil Action Pathway；Alprenolol Action Pathway；Alvimopan Action Pathway；Amiloride Action Pathway；Amiodarone Action Pathway；Amlodipine Action Pathway；Anileridine Action Pathway；Arbutamine Action Pathway；Total 139 pathways, visit the HMDB page for details